+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Parenteral Excipients Market - Global Forecast 2026-2032- Product Image
Parenteral Excipients Market - Global Forecast 2026-2032- Product Image
Sale

Parenteral Excipients Market - Global Forecast 2026-2032

  • Report

  • 183 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6277813
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Parenteral Excipients: Executive Overview

Parenteral excipients are inactive ingredients used in injectable medicines to support stability, solubility, preservation, buffering, tonicity, viscosity, and controlled delivery. Their importance is rising alongside more complex biologics, vaccines, peptide therapies, long-acting injectables, and other products that require tightly controlled formulation performance. Regulatory scrutiny, sterility expectations, supply assurance, and compatibility with sensitive active ingredients are central considerations for developers and manufacturers.

Formulation Complexity Is Reshaping Excipient Selection

The landscape is shifting from largely conventional formulation support toward excipient systems designed for complex and sensitive drug substances. Developers increasingly evaluate oxidation control, aggregation prevention, container compatibility, injection comfort, and manufacturability at the same time. These requirements are encouraging stronger collaboration among drug developers, contract manufacturers, analytical laboratories, and specialized ingredient suppliers. Quality-by-design practices and expanded characterization are also making excipient functionality, impurity profiles, and process consistency more consequential during development and scale-up.

Artificial Intelligence Strengthens Formulation and Quality Decisions

Artificial intelligence can improve parenteral-excipient development by identifying relationships among excipient attributes, active-ingredient properties, process conditions, and stability outcomes. Machine-learning models may help prioritize formulation experiments, detect atypical analytical results, optimize process parameters, and support predictive maintenance and documentation review. However, reliable use depends on representative datasets, validated workflows, explainable outputs, strong data governance, and human oversight. AI should therefore complement, rather than replace, experimental verification, pharmaceutical development expertise, and regulatory accountability.

Regional Priorities Differ Across the Global Supply Network

North America emphasizes advanced biologics development, regulatory compliance, domestic resilience, and high-quality injectable manufacturing. Europe combines stringent quality expectations with strong interest in sustainable production, harmonized requirements, and specialized biologic formulation. Asia-Pacific is important for pharmaceutical manufacturing, biosimilars, vaccines, and expanding development capabilities, while supply-chain localization remains a strategic priority. Latin America is shaped by public-health procurement, import dependence, and the modernization of local pharmaceutical production. The Middle East is investing in healthcare capacity, manufacturing partnerships, and supply security. Africa continues to prioritize access, essential medicines, technology transfer, and dependable quality systems as pharmaceutical capabilities develop.

Economic and Security Groups Shape Procurement and Compliance

ASEAN economies are strengthening regional pharmaceutical manufacturing and supply-chain connectivity, with varying levels of regulatory maturity across member states. BRICS members are pursuing greater production autonomy, local manufacturing, and diversified sourcing, although implementation differs by country. The European Union benefits from regulatory coordination and established quality frameworks, while the G7 places emphasis on advanced therapies, resilience, and high standards for pharmaceutical inputs. GCC countries are expanding healthcare infrastructure and local production ambitions, increasing interest in dependable qualified suppliers. NATO members, considered collectively, are also attentive to resilient medical supply chains and continuity of critical healthcare manufacturing, without implying a single procurement or regulatory policy.

Country-Level Capabilities and Priorities Are Uneven

The United States and Canada combine sophisticated pharmaceutical development with strong regulatory and quality-system expectations. Germany, France, Italy, Spain, and the United Kingdom have established pharmaceutical and biotechnology ecosystems, with particular attention to compliance, sustainability, and advanced therapies. China and India are major manufacturing and development centers, while quality harmonization, specialized capability, and supply assurance remain important strategic themes. Japan emphasizes precision manufacturing, quality consistency, and advanced injectable products. South Korea is strengthening biologics and contract manufacturing capabilities. Australia supports research-led development and regulated supply chains. Brazil and Mexico serve important Latin American pharmaceutical markets, where local production, procurement efficiency, and dependable access remain central concerns. Russia retains pharmaceutical manufacturing and scientific capabilities, while external trade and supply constraints can complicate access to specialized inputs.

Priorities for Leaders in Parenteral Excipient Strategy

Leaders should qualify multiple sources for critical excipients, map upstream dependencies, and maintain risk-based contingency plans for transportation, capacity, and regulatory disruption. Excipient selection should be integrated early with active-ingredient characterization, container-closure assessment, sterilization strategy, and intended administration route. Organizations should strengthen supplier audits, change-control agreements, analytical comparability, and documentation readiness. Investment in formulation databases and carefully governed AI tools can improve experiment prioritization, but every model-supported decision should remain traceable and experimentally confirmed. Sustainability programs should address solvent use, waste, packaging, energy intensity, and lifecycle impacts without compromising sterility or product performance.

Research Methodology for the Executive Summary

This executive summary is based on a structured qualitative assessment of parenteral-excipient applications, formulation requirements, manufacturing practices, regulatory considerations, technology trends, and supply-chain dynamics. Insights were organized across the requested regions, economic and security groups, and countries, with emphasis on verifiable industry characteristics rather than numerical market claims. The assessment distinguishes broad strategic patterns from jurisdiction-specific conditions and avoids market estimates, shares, forecasts, and unsupported company-level assertions. Country and group comparisons should be interpreted in context because regulatory systems, manufacturing depth, public procurement, and data availability differ materially.

Resilient, Evidence-Led Excipient Management Will Define Progress

Parenteral excipients are becoming more strategically important as injectable medicines grow more complex and quality expectations intensify. Success will depend on combining rigorous material characterization, resilient sourcing, robust manufacturing controls, regulatory readiness, and disciplined adoption of digital and AI-enabled tools. Organizations that treat excipients as critical formulation and supply-chain components-not merely secondary ingredients-will be better positioned to support reliable development, consistent production, and patient-focused performance across diverse healthcare systems.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Parenteral Excipients Market, by Excipient Type
7.1. Introduction
7.2. Antioxidants
7.3. Buffers & Tonicity Agents
7.3.1. Citrate Buffers
7.3.2. Phosphate Buffers
7.3.3. Sodium Chloride And Tonicity Adjusters
7.4. Bulking Agents & Lyoprotectants
7.4.1. Lyoprotectants (Trehalose, Sucrose)
7.4.2. Sugars As Bulking Agents (Sucrose, Mannitol)
7.5. Chelating Agents
7.6. pH Adjusters
7.7. Preservatives
7.8. Solvents & Cosolvents
7.8.1. Cosolvents (Ethanol, Propylene Glycol)
7.8.2. Polyol Solvents (Glycerol, Sorbitol)
7.8.3. Water For Injection
7.9. Stabilizers
7.9.1. Amino Acids (Histidine, Glycine)
7.9.2. Protein Stabilizers (Albumin, Polymers)
7.10. Surfactants
7.10.1. Lecithin And Phospholipids
7.10.2. Poloxamers
7.10.3. Polysorbates
7.11. Viscosity Modifiers
8. Parenteral Excipients Market, by Route Of Administration
8.1. Introduction
8.2. Intramuscular
8.3. Intrathecal And Other Specialized Routes
8.4. Intravenous
8.5. Ophthalmic Injection
8.6. Subcutaneous
9. Parenteral Excipients Market, by Formulation Type
9.1. Introduction
9.2. Aqueous Solution
9.3. Emulsion
9.4. Liposomal And Nanoparticle Systems
9.5. Lyophilized Powder
9.6. Suspension
10. Parenteral Excipients Market, by Dosage Format
10.1. Introduction
10.2. Ampoules
10.3. Cartridges And Pods
10.4. Multi Dose Vials
10.5. Prefilled Syringes
10.6. Vials (Single Dose)
11. Parenteral Excipients Market, by Product Grade
11.1. Introduction
11.2. Analytical And Research Grade
11.3. Injectable Grade
11.4. USP/EP Compliant Grade
12. Parenteral Excipients Market, by Therapeutic Area
12.1. Introduction
12.2. Cardiology
12.3. Diabetes And Endocrinology
12.4. Infectious Diseases
12.5. Neurology
12.6. Oncology
12.7. Ophthalmology
12.8. Vaccines And Immunotherapy
13. Parenteral Excipients Market, by Drug Type
13.1. Introduction
13.2. Advanced Delivery Systems
13.3. Biologics
13.4. Small Molecule Injectables
14. Parenteral Excipients Market, by End User
14.1. Introduction
14.2. Contract Development And Manufacturing Organizations
14.3. Generic Manufacturers
14.4. Hospitals And Clinics
14.5. Pharmaceutical And Biotech Companies
14.6. Research Institutions And Academia
14.7. Veterinary Manufacturers
15. Parenteral Excipients Market, by Distribution Channel
15.1. Introduction
15.2. Direct Sales To Manufacturers
15.3. Distributors And Traders
15.4. Online Marketplaces And E Commerce
15.5. Third Party Suppliers And Toll Manufacturers
16. Parenteral Excipients Market, by Region
16.1. Introduction
16.2. Asia-Pacific
16.3. North America
16.4. Latin America
16.5. Europe
16.6. Middle East
16.7. Africa
17. Parenteral Excipients Market, by Group
17.1. Introduction
17.2. ASEAN
17.3. GCC
17.4. European Union
17.5. BRICS
17.6. G7
17.7. NATO
18. Parenteral Excipients Market, by Country
18.1. Introduction
18.2. United States
18.3. Canada
18.4. Mexico
18.5. Brazil
18.6. United Kingdom
18.7. Germany
18.8. France
18.9. Russia
18.10. Italy
18.11. Spain
18.12. China
18.13. India
18.14. Japan
18.15. Australia
18.16. South Korea
19. Competitive Landscape
19.1. Market Share Analysis, 2025
19.2. Market Concentration Analysis, 2025
19.2.1. Concentration Ratio (CR)
19.2.2. Herfindahl Hirschman Index (HHI)
19.3. Recent Developments & Impact Analysis, 2025
19.4. Product Portfolio Analysis, 2025
19.5. Benchmarking Analysis, 2025
20. Company Profiles
20.1. ABITEC Corporation
20.2. Actylis
20.3. Archer Daniels Midland Company
20.4. Ashland Inc
20.5. BASF SE
20.6. Clariant AG
20.7. Colorcon Inc.
20.8. Croda International Plc
20.9. DFE Pharma GmbH & Co KG
20.10. DuPont de Nemours Inc.
20.11. Evonik Industries AG
20.12. Fuji Chemical Industries Co. Ltd.
20.13. GATTEFOSSE SAS
20.14. Innophos Holdings Inc.
20.15. International Flavors & Fragrances Inc.
20.16. JRS PHARMA GmbH + Co. KG
20.17. Kerry Group P.L.C.
20.18. Lipoid GmbH
20.19. MEGGLE GmbH & Co. KG
20.20. Merck KGaA
20.21. NOF Corporation
20.22. Roquette Frères S.A.
20.23. Shin-Etsu Chemical Co. Ltd.
20.24. SPI Pharma Inc.
20.25. The Lubrizol Corporation
21. Key Experts
LIST OF FIGURES
FIGURE 1. Global Parenteral Excipients Market, Years Considered for the Study
FIGURE 2. Global Parenteral Excipients Market, Research Design
FIGURE 3. Global Parenteral Excipients Market, Research Framework
FIGURE 4. Global Parenteral Excipients Market, Data Triangulation
FIGURE 5. Global Parenteral Excipients Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Parenteral Excipients Market Size, by Excipient Type, 2025 vs 2032 (%)
FIGURE 7. Global Parenteral Excipients Market Size, by Excipient Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Parenteral Excipients Market Size, by Route Of Administration, 2025 vs 2032 (%)
FIGURE 9. Global Parenteral Excipients Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Parenteral Excipients Market Size, by Formulation Type, 2025 vs 2032 (%)
FIGURE 11. Global Parenteral Excipients Market Size, by Formulation Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Parenteral Excipients Market Size, by Dosage Format, 2025 vs 2032 (%)
FIGURE 13. Global Parenteral Excipients Market Size, by Dosage Format, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Parenteral Excipients Market Size, by Product Grade, 2025 vs 2032 (%)
FIGURE 15. Global Parenteral Excipients Market Size, by Product Grade, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Parenteral Excipients Market Size, by Therapeutic Area, 2025 vs 2032 (%)
FIGURE 17. Global Parenteral Excipients Market Size, by Therapeutic Area, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Parenteral Excipients Market Size, by Drug Type, 2025 vs 2032 (%)
FIGURE 19. Global Parenteral Excipients Market Size, by Drug Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Parenteral Excipients Market Size, by End User, 2025 vs 2032 (%)
FIGURE 21. Global Parenteral Excipients Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 22. Global Parenteral Excipients Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 23. Global Parenteral Excipients Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 24. Global Parenteral Excipients Market Size, by Region, 2025 vs 2032 (%)
FIGURE 25. Global Parenteral Excipients Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 26. Global Parenteral Excipients Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 27. Global Parenteral Excipients Market Size, by Country, 2025 vs 2032 (%)
FIGURE 28. Global Parenteral Excipients Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 29. Global Parenteral Excipients Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Parenteral Excipients Market Segmentation & Coverage
TABLE 2. Global Parenteral Excipients Market Size, 2017-2032 (USD Million)
TABLE 3. Global Parenteral Excipients Market Size, by Excipient Type, 2017-2032 (USD Million)
TABLE 4. Global Antioxidants Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Antioxidants Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Antioxidants Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Buffers & Tonicity Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Buffers & Tonicity Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Buffers & Tonicity Agents Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Citrate Buffers Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Citrate Buffers Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Citrate Buffers Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Phosphate Buffers Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Phosphate Buffers Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Phosphate Buffers Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Sodium Chloride And Tonicity Adjusters Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Sodium Chloride And Tonicity Adjusters Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Sodium Chloride And Tonicity Adjusters Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Bulking Agents & Lyoprotectants Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Bulking Agents & Lyoprotectants Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Bulking Agents & Lyoprotectants Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Lyoprotectants (Trehalose, Sucrose) Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Lyoprotectants (Trehalose, Sucrose) Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Lyoprotectants (Trehalose, Sucrose) Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Sugars As Bulking Agents (Sucrose, Mannitol) Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Sugars As Bulking Agents (Sucrose, Mannitol) Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Sugars As Bulking Agents (Sucrose, Mannitol) Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Chelating Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Chelating Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Chelating Agents Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global pH Adjusters Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global pH Adjusters Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global pH Adjusters Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Preservatives Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Preservatives Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Preservatives Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Solvents & Cosolvents Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Solvents & Cosolvents Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Solvents & Cosolvents Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Cosolvents (Ethanol, Propylene Glycol) Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Cosolvents (Ethanol, Propylene Glycol) Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Cosolvents (Ethanol, Propylene Glycol) Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Polyol Solvents (Glycerol, Sorbitol) Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Polyol Solvents (Glycerol, Sorbitol) Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Polyol Solvents (Glycerol, Sorbitol) Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Water For Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Water For Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Water For Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Stabilizers Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Stabilizers Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Stabilizers Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Amino Acids (Histidine, Glycine) Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Amino Acids (Histidine, Glycine) Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Amino Acids (Histidine, Glycine) Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Protein Stabilizers (Albumin, Polymers) Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Protein Stabilizers (Albumin, Polymers) Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Protein Stabilizers (Albumin, Polymers) Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Surfactants Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Surfactants Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Surfactants Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Lecithin And Phospholipids Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Lecithin And Phospholipids Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Lecithin And Phospholipids Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Poloxamers Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Poloxamers Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Poloxamers Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Polysorbates Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Polysorbates Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Polysorbates Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Viscosity Modifiers Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Viscosity Modifiers Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Viscosity Modifiers Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Parenteral Excipients Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 74. Global Intramuscular Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Intramuscular Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Intramuscular Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Intrathecal And Other Specialized Routes Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Intrathecal And Other Specialized Routes Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Intrathecal And Other Specialized Routes Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Intravenous Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Intravenous Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Intravenous Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Ophthalmic Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Ophthalmic Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Ophthalmic Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Subcutaneous Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Subcutaneous Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Subcutaneous Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Parenteral Excipients Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 90. Global Aqueous Solution Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Aqueous Solution Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Aqueous Solution Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Emulsion Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Emulsion Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Emulsion Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Liposomal And Nanoparticle Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Global Liposomal And Nanoparticle Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. Global Liposomal And Nanoparticle Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 99. Global Lyophilized Powder Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Global Lyophilized Powder Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. Global Lyophilized Powder Market Size, by Country, 2017-2032 (USD Million)
TABLE 102. Global Suspension Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Global Suspension Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. Global Suspension Market Size, by Country, 2017-2032 (USD Million)
TABLE 105. Global Parenteral Excipients Market Size, by Dosage Format, 2017-2032 (USD Million)
TABLE 106. Global Ampoules Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Ampoules Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Ampoules Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Cartridges And Pods Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Cartridges And Pods Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Cartridges And Pods Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Multi Dose Vials Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Multi Dose Vials Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Multi Dose Vials Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Prefilled Syringes Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Global Prefilled Syringes Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. Global Prefilled Syringes Market Size, by Country, 2017-2032 (USD Million)
TABLE 118. Global Vials (Single Dose) Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Global Vials (Single Dose) Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. Global Vials (Single Dose) Market Size, by Country, 2017-2032 (USD Million)
TABLE 121. Global Parenteral Excipients Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 122. Global Analytical And Research Grade Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Global Analytical And Research Grade Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. Global Analytical And Research Grade Market Size, by Country, 2017-2032 (USD Million)
TABLE 125. Global Injectable Grade Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Global Injectable Grade Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. Global Injectable Grade Market Size, by Country, 2017-2032 (USD Million)
TABLE 128. Global USP/EP Compliant Grade Market Size, by Region, 2017-2032 (USD Million)
TABLE 129. Global USP/EP Compliant Grade Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. Global USP/EP Compliant Grade Market Size, by Country, 2017-2032 (USD Million)
TABLE 131. Global Parenteral Excipients Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 132. Global Cardiology Market Size, by Region, 2017-2032 (USD Million)
TABLE 133. Global Cardiology Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. Global Cardiology Market Size, by Country, 2017-2032 (USD Million)
TABLE 135. Global Diabetes And Endocrinology Market Size, by Region, 2017-2032 (USD Million)
TABLE 136. Global Diabetes And Endocrinology Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. Global Diabetes And Endocrinology Market Size, by Country, 2017-2032 (USD Million)
TABLE 138. Global Infectious Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 139. Global Infectious Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 140. Global Infectious Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 141. Global Neurology Market Size, by Region, 2017-2032 (USD Million)
TABLE 142. Global Neurology Market Size, by Group, 2017-2032 (USD Million)
TABLE 143. Global Neurology Market Size, by Country, 2017-2032 (USD Million)
TABLE 144. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 145. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 146. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 147. Global Ophthalmology Market Size, by Region, 2017-2032 (USD Million)
TABLE 148. Global Ophthalmology Market Size, by Group, 2017-2032 (USD Million)
TABLE 149. Global Ophthalmology Market Size, by Country, 2017-2032 (USD Million)
TABLE 150. Global Vaccines And Immunotherapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 151. Global Vaccines And Immunotherapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 152. Global Vaccines And Immunotherapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 153. Global Parenteral Excipients Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 154. Global Advanced Delivery Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 155. Global Advanced Delivery Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 156. Global Advanced Delivery Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 157. Global Biologics Market Size, by Region, 2017-2032 (USD Million)
TABLE 158. Global Biologics Market Size, by Group, 2017-2032 (USD Million)
TABLE 159. Global Biologics Market Size, by Country, 2017-2032 (USD Million)
TABLE 160. Global Small Molecule Injectables Market Size, by Region, 2017-2032 (USD Million)
TABLE 161. Global Small Molecule Injectables Market Size, by Group, 2017-2032 (USD Million)
TABLE 162. Global Small Molecule Injectables Market Size, by Country, 2017-2032 (USD Million)
TABLE 163. Global Parenteral Excipients Market Size, by End User, 2017-2032 (USD Million)
TABLE 164. Global Contract Development And Manufacturing Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 165. Global Contract Development And Manufacturing Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 166. Global Contract Development And Manufacturing Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 167. Global Generic Manufacturers Market Size, by Region, 2017-2032 (USD Million)
TABLE 168. Global Generic Manufacturers Market Size, by Group, 2017-2032 (USD Million)
TABLE 169. Global Generic Manufacturers Market Size, by Country, 2017-2032 (USD Million)
TABLE 170. Global Hospitals And Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 171. Global Hospitals And Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 172. Global Hospitals And Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 173. Global Pharmaceutical And Biotech Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 174. Global Pharmaceutical And Biotech Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 175. Global Pharmaceutical And Biotech Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 176. Global Research Institutions And Academia Market Size, by Region, 2017-2032 (USD Million)
TABLE 177. Global Research Institutions And Academia Market Size, by Group, 2017-2032 (USD Million)
TABLE 178. Global Research Institutions And Academia Market Size, by Country, 2017-2032 (USD Million)
TABLE 179. Global Veterinary Manufacturers Market Size, by Region, 2017-2032 (USD Million)
TABLE 180. Global Veterinary Manufacturers Market Size, by Group, 2017-2032 (USD Million)
TABLE 181. Global Veterinary Manufacturers Market Size, by Country, 2017-2032 (USD Million)
TABLE 182. Global Parenteral Excipients Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 183. Global Direct Sales To Manufacturers Market Size, by Region, 2017-2032 (USD Million)
TABLE 184. Global Direct Sales To Manufacturers Market Size, by Group, 2017-2032 (USD Million)
TABLE 185. Global Direct Sales To Manufacturers Market Size, by Country, 2017-2032 (USD Million)
TABLE 186. Global Distributors And Traders Market Size, by Region, 2017-2032 (USD Million)
TABLE 187. Global Distributors And Traders Market Size, by Group, 2017-2032 (USD Million)
TABLE 188. Global Distributors And Traders Market Size, by Country, 2017-2032 (USD Million)
TABLE 189. Global Online Marketplaces And E Commerce Market Size, by Region, 2017-2032 (USD Million)
TABLE 190. Global Online Marketplaces And E Commerce Market Size, by Group, 2017-2032 (USD Million)
TABLE 191. Global Online Marketplaces And E Commerce Market Size, by Country, 2017-2032 (USD Million)
TABLE 192. Global Third Party Suppliers And Toll Manufacturers Market Size, by Region, 2017-2032 (USD Million)
TABLE 193. Global Third Party Suppliers And Toll Manufacturers Market Size, by Group, 2017-2032 (USD Million)
TABLE 194. Global Third Party Suppliers And Toll Manufacturers Market Size, by Country, 2017-2032 (USD Million)
TABLE 195. Global Parenteral Excipients Market Size, by Region, 2017-2032 (USD Million)
TABLE 196. Asia-Pacific Parenteral Excipients Market Size, by Region, 2017-2032 (USD Million)
TABLE 197. Asia-Pacific Parenteral Excipients Market Size, by Excipient Type, 2017-2032 (USD Million)
TABLE 198. Asia-Pacific Parenteral Excipients Market Size, by Buffers & Tonicity Agents, 2017-2032 (USD Million)
TABLE 199. Asia-Pacific Parenteral Excipients Market Size, by Bulking Agents & Lyoprotectants, 2017-2032 (USD Million)
TABLE 200. Asia-Pacific Parenteral Excipients Market Size, by Solvents & Cosolvents, 2017-2032 (USD Million)
TABLE 201. Asia-Pacific Parenteral Excipients Market Size, by Stabilizers, 2017-2032 (USD Million)
TABLE 202. Asia-Pacific Parenteral Excipients Market Size, by Surfactants, 2017-2032 (USD Million)
TABLE 203. Asia-Pacific Parenteral Excipients Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 204. Asia-Pacific Parenteral Excipients Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 205. Asia-Pacific Parenteral Excipients Market Size, by Dosage Format, 2017-2032 (USD Million)
TABLE 206. Asia-Pacific Parenteral Excipients Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 207. Asia-Pacific Parenteral Excipients Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 208. Asia-Pacific Parenteral Excipients Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 209. Asia-Pacific Parenteral Excipients Market Size, by End User, 2017-2032 (USD Million)
TABLE 210. Asia-Pacific Parenteral Excipients Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 211. North America Parenteral Excipients Market Size, by Region, 2017-2032 (USD Million)
TABLE 212. North America Parenteral Excipients Market Size, by Excipient Type, 2017-2032 (USD Million)
TABLE 213. North America Parenteral Excipients Market Size, by Buffers & Tonicity Agents, 2017-2032 (USD Million)
TABLE 214. North America Parenteral Excipients Market Size, by Bulking Agents & Lyoprotectants, 2017-2032 (USD Million)
TABLE 215. North America Parenteral Excipients Market Size, by Solvents & Cosolvents, 2017-2032 (USD Million)
TABLE 216. North America Parenteral Excipients Market Size, by Stabilizers, 2017-2032 (USD Million)
TABLE 217. North America Parenteral Excipients Market Size, by Surfactants, 2017-2032 (USD Million)
TABLE 218. North America Parenteral Excipients Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 219. North America Parenteral Excipients Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 220. North America Parenteral Excipients Market Size, by Dosage Format, 2017-2032 (USD Million)
TABLE 221. North America Parenteral Excipients Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 222. North America Parenteral Excipients Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 223. North America Parenteral Excipients Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 224. North America Parenteral Excipients Market Size, by End User, 2017-2032 (USD Million)
TABLE 225. North America Parenteral Excipients Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 226. Latin America Parenteral Excipients Market Size, by Region, 2017-2032 (USD Million)
TABLE 227. Latin America Parenteral Excipients Market Size, by Excipient Type, 2017-2032 (USD Million)
TABLE 228. Latin America Parenteral Excipients Market Size, by Buffers & Tonicity Agents, 2017-2032 (USD Million)
TABLE 229. Latin America Parenteral Excipients Market Size, by Bulking Agents & Lyoprotectants, 2017-2032 (USD Million)
TABLE 230. Latin America Parenteral Excipients Market Size, by Solvents & Cosolvents, 2017-2032 (USD Million)
TABLE 231. Latin America Parenteral Excipients Market Size, by Stabilizers, 2017-2032 (USD Million)
TABLE 232. Latin America Parenteral Excipients Market Size, by Surfactants, 2017-2032 (USD Million)
TABLE 233. Latin America Parenteral Excipients Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 234. Latin America Parenteral Excipients Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 235. Latin America Parenteral Excipients Market Size, by Dosage Format, 2017-2032 (USD Million)
TABLE 236. Latin America Parenteral Excipients Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 237. Latin America Parenteral Excipients Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 238. Latin America Parenteral Excipients Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 239. Latin America Parenteral Excipients Market Size, by End User, 2017-2032 (USD Million)
TABLE 240. Latin America Parenteral Excipients Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 241. Europe Parenteral Excipients Market Size, by Region, 2017-2032 (USD Million)
TABLE 242. Europe Parenteral Excipients Market Size, by Excipient Type, 2017-2032 (USD Million)
TABLE 243. Europe Parenteral Excipients Market Size, by Buffers & Tonicity Agents, 2017-2032 (USD Million)
TABLE 244. Europe Parenteral Excipients Market Size, by Bulking Agents & Lyoprotectants, 2017-2032 (USD Million)
TABLE 245. Europe Parenteral Excipients Market Size, by Solvents & Cosolvents, 2017-2032 (USD Million)
TABLE 246. Europe Parenteral Excipients Market Size, by Stabilizers, 2017-2032 (USD Million)
TABLE 247. Europe Parenteral Excipients Market Size, by Surfactants, 2017-2032 (USD Million)
TABLE 248. Europe Parenteral Excipients Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 249. Europe Parenteral Excipients Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 250. Europe Parenteral Excipients Market Size, by Dosage Format, 2017-2032 (USD Million)
TABLE 251. Europe Parenteral Excipients Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 252. Europe Parenteral Excipients Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 253. Europe Parenteral Excipients Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 254. Europe Parenteral Excipients Market Size, by End User, 2017-2032 (USD Million)
TABLE 255. Europe Parenteral Excipients Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 256. Middle East Parenteral Excipients Market Size, by Region, 2017-2032 (USD Million)
TABLE 257. Middle East Parenteral Excipients Market Size, by Excipient Type, 2017-2032 (USD Million)
TABLE 258. Middle East Parenteral Excipients Market Size, by Buffers & Tonicity Agents, 2017-2032 (USD Million)
TABLE 259. Middle East Parenteral Excipients Market Size, by Bulking Agents & Lyoprotectants, 2017-2032 (USD Million)
TABLE 260. Middle East Parenteral Excipients Market Size, by Solvents & Cosolvents, 2017-2032 (USD Million)
TABLE 261. Middle East Parenteral Excipients Market Size, by Stabilizers, 2017-2032 (USD Million)
TABLE 262. Middle East Parenteral Excipients Market Size, by Surfactants, 2017-2032 (USD Million)
TABLE 263. Middle East Parenteral Excipients Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 264. Middle East Parenteral Excipients Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 265. Middle East Parenteral Excipients Market Size, by Dosage Format, 2017-2032 (USD Million)
TABLE 266. Middle East Parenteral Excipients Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 267. Middle East Parenteral Excipients Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 268. Middle East Parenteral Excipients Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 269. Middle East Parenteral Excipients Market Size, by End User, 2017-2032 (USD Million)
TABLE 270. Middle East Parenteral Excipients Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 271. Africa Parenteral Excipients Market Size, by Region, 2017-2032 (USD Million)
TABLE 272. Africa Parenteral Excipients Market Size, by Excipient Type, 2017-2032 (USD Million)
TABLE 273. Africa Parenteral Excipients Market Size, by Buffers & Tonicity Agents, 2017-2032 (USD Million)
TABLE 274. Africa Parenteral Excipients Market Size, by Bulking Agents & Lyoprotectants, 2017-2032 (USD Million)
TABLE 275. Africa Parenteral Excipients Market Size, by Solvents & Cosolvents, 2017-2032 (USD Million)
TABLE 276. Africa Parenteral Excipients Market Size, by Stabilizers, 2017-2032 (USD Million)
TABLE 277. Africa Parenteral Excipients Market Size, by Surfactants, 2017-2032 (USD Million)
TABLE 278. Africa Parenteral Excipients Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 279. Africa Parenteral Excipients Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 280. Africa Parenteral Excipients Market Size, by Dosage Format, 2017-2032 (USD Million)
TABLE 281. Africa Parenteral Excipients Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 282. Africa Parenteral Excipients Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 283. Africa Parenteral Excipients Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 284. Africa Parenteral Excipients Market Size, by End User, 2017-2032 (USD Million)
TABLE 285. Africa Parenteral Excipients Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 286. Global Parenteral Excipients Market Size, by Group, 2017-2032 (USD Million)
TABLE 287. ASEAN Parenteral Excipients Market Size, by Group, 2017-2032 (USD Million)
TABLE 288. ASEAN Parenteral Excipients Market Size, by Excipient Type, 2017-2032 (USD Million)
TABLE 289. ASEAN Parenteral Excipients Market Size, by Buffers & Tonicity Agents, 2017-2032 (USD Million)
TABLE 290. ASEAN Parenteral Excipients Market Size, by Bulking Agents & Lyoprotectants, 2017-2032 (USD Million)
TABLE 291. ASEAN Parenteral Excipients Market Size, by Solvents & Cosolvents, 2017-2032 (USD Million)
TABLE 292. ASEAN Parenteral Excipients Market Size, by Stabilizers, 2017-2032 (USD Million)
TABLE 293. ASEAN Parenteral Excipients Market Size, by Surfactants, 2017-2032 (USD Million)
TABLE 294. ASEAN Parenteral Excipients Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 295. ASEAN Parenteral Excipients Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 296. ASEAN Parenteral Excipients Market Size, by Dosage Format, 2017-2032 (USD Million)
TABLE 297. ASEAN Parenteral Excipients Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 298. ASEAN Parenteral Excipients Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 299. ASEAN Parenteral Excipients Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 300. ASEAN Parenteral Excipients Market Size, by End User, 2017-2032 (USD Million)
TABLE 301. ASEAN Parenteral Excipients Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 302. GCC Parenteral Excipients Market Size, by Group, 2017-2032 (USD Million)
TABLE 303. GCC Parenteral Excipients Market Size, by Excipient Type, 2017-2032 (USD Million)
TABLE 304. GCC Parenteral Excipients Market Size, by Buffers & Tonicity Agents, 2017-2032 (USD Million)
TABLE 305. GCC Parenteral Excipients Market Size, by Bulking Agents & Lyoprotectants, 2017-2032 (USD Million)
TABLE 306. GCC Parenteral Excipients Market Size, by Solvents & Cosolvents, 2017-2032 (USD Million)
TABLE 307. GCC Parenteral Excipients Market Size, by Stabilizers, 2017-2032 (USD Million)
TABLE 308. GCC Parenteral Excipients Market Size, by Surfactants, 2017-2032 (USD Million)
TABLE 309. GCC Parenteral Excipients Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 310. GCC Parenteral Excipients Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 311. GCC Parenteral Excipients Market Size, by Dosage Format, 2017-2032 (USD Million)
TABLE 312. GCC Parenteral Excipients Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 313. GCC Parenteral Excipients Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 314. GCC Parenteral Excipients Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 315. GCC Parenteral Excipients Market Size, by End User, 2017-2032 (USD Million)
TABLE 316. GCC Parenteral Excipients Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 317. European Union Parenteral Excipients Market Size, by Group, 2017-2032 (USD Million)
TABLE 318. European Union Parenteral Excipients Market Size, by Excipient Type, 2017-2032 (USD Million)
TABLE 319. European Union Parenteral Excipients Market Size, by Buffers & Tonicity Agents, 2017-2032 (USD Million)
TABLE 320. European Union Parenteral Excipients Market Size, by Bulking Agents & Lyoprotectants, 2017-2032 (USD Million)
TABLE 321. European Union Parenteral Excipients Market Size, by Solvents & Cosolvents, 2017-2032 (USD Million)
TABLE 322. European Union Parenteral Excipients Market Size, by Stabilizers, 2017-2032 (USD Million)
TABLE 323. European Union Parenteral Excipients Market Size, by Surfactants, 2017-2032 (USD Million)
TABLE 324. European Union Parenteral Excipients Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 325. European Union Parenteral Excipients Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 326. European Union Parenteral Excipients Market Size, by Dosage Format, 2017-2032 (USD Million)
TABLE 327. European Union Parenteral Excipients Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 328. European Union Parenteral Excipients Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 329. European Union Parenteral Excipients Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 330. European Union Parenteral Excipients Market Size, by End User, 2017-2032 (USD Million)
TABLE 331. European Union Parenteral Excipients Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 332. BRICS Parenteral Excipients Market Size, by Group, 2017-2032 (USD Million)
TABLE 333. BRICS Parenteral Excipients Market Size, by Excipient Type, 2017-2032 (USD Million)
TABLE 334. BRICS Parenteral Excipients Market Size, by Buffers & Tonicity Agents, 2017-2032 (USD Million)
TABLE 335. BRICS Parenteral Excipients Market Size, by Bulking Agents & Lyoprotectants, 2017-2032 (USD Million)
TABLE 336. BRICS Parenteral Excipients Market Size, by Solvents & Cosolvents, 2017-2032 (USD Million)
TABLE 337. BRICS Parenteral Excipients Market Size, by Stabilizers, 2017-2032 (USD Million)
TABLE 338. BRICS Parenteral Excipients Market Size, by Surfactants, 2017-2032 (USD Million)
TABLE 339. BRICS Parenteral Excipients Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 340. BRICS Parenteral Excipients Market Size, by Formulation Type, 2017-2032 (USD Million)
TABLE 341. BRICS Parenteral Excipients Market Size, by Dosage Format, 2017-2032 (USD Million)
TABLE 342. BRICS Parenteral Excipients Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 343. BRICS Parenteral Excipients Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 344. BRICS Parenteral Excipients Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 345. BRICS Parenteral Excipients Market Size, by End User, 2017-2032 (USD Million)
TABLE 346. BRICS Parenteral Excipients Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 347. G7 Parenteral Excipients Market Size, by Group, 2017-2032 (USD Million)
TABLE 348. G7 Parenteral Excipients Market Size, by Excipient Type, 2017-2032 (USD Million)
TABLE 349. G7 Parenteral Excipients Market Size, by Buffers & Tonicity Agents, 2017-2032 (USD Million)
TA

Companies Mentioned

  • ABITEC Corporation
  • Actylis
  • Archer Daniels Midland Company
  • Ashland Inc
  • BASF SE
  • Clariant AG
  • Colorcon Inc.
  • Croda International Plc
  • DFE Pharma GmbH & Co KG
  • DuPont de Nemours Inc.
  • Evonik Industries AG
  • Fuji Chemical Industries Co. Ltd.
  • GATTEFOSSE SAS
  • Innophos Holdings Inc.
  • International Flavors & Fragrances Inc.
  • JRS PHARMA GmbH + Co. KG
  • Kerry Group P.L.C.
  • Lipoid GmbH
  • MEGGLE GmbH & Co. KG
  • Merck KGaA
  • NOF Corporation
  • Roquette Frères S.A.
  • Shin-Etsu Chemical Co. Ltd.
  • SPI Pharma Inc.
  • The Lubrizol Corporation

Related Topics

Related Reports

Lipid-Based Pharma Excipients Market - Global Forecast 2026-2032 - Product Image

Lipid-Based Pharma Excipients Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Pharmaceutical Carbohydrate Excipients Market - Global Forecast 2026-2032 - Product Image

Pharmaceutical Carbohydrate Excipients Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Pharmaceutical pH Modifier Excipients Market - Global Forecast 2026-2032 - Product Image

Pharmaceutical pH Modifier Excipients Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Biologic Excipients - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Biologic Excipients - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 180 Pages
  • Global
From
Pharmaceutical Oils Excipients Market - Global Forecast 2026-2032 - Product Image

Pharmaceutical Oils Excipients Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.